Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

CATX | Perspective Therapeutics Inc

Index- P/E- EPS (ttm)-0.07 Insider Own27.54% Shs Outstand- Perf Week5.36%
Market Cap82.77M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float203.29M Perf Month-24.65%
Income-14.90M PEG- EPS next Q-0.04 Inst Own11.75% Short Float / Ratio0.78% / 1.62 Perf Quarter-53.91%
Sales9.57M P/S8.65 EPS this Y- Inst Trans-2.20% Short Interest1.58M Perf Half Y-54.44%
Book/sh0.39 P/B0.76 EPS next Y- ROA-15.90% Target Price1.20 Perf Year6.54%
Cash/sh0.10 P/C2.92 EPS next 5Y- ROE-17.22% 52W Range0.20 - 0.73 Perf YTD19.38%
Dividend- P/FCF- EPS past 5Y14.18% ROI-13.44% 52W High-59.58% Beta1.70
Dividend %- Quick Ratio3.59 Sales past 5Y- Gross Margin32.43% 52W Low43.90% ATR0.04
Employees- Current Ratio3.72 Sales Q/Q-16.65% Oper. Margin-224.50% RSI (14)41.91 Volatility9.33% 17.50%
OptionableNo Debt/Eq0.02 EPS Q/Q-171.92% Profit Margin-155.78% Rel Volume0.79 Prev Close0.27
ShortableYes LT Debt/Eq0.02 EarningsAug 11 BMO Payout- Avg Volume976.70K Price0.29
Recom1.00 SMA20-6.43% SMA50-27.86% SMA200-38.48% Volume772,489 Change8.46%
Sep-12-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 08:17AM
Aug-28-23 08:00AM
Aug-11-23 09:15AM
08:11AM Loading…
Aug-09-23 08:05AM
Jun-27-23 08:00AM
Jun-21-23 08:00AM
Jun-16-23 08:00AM
Jun-08-23 08:00AM
May-28-23 06:36PM
May-24-23 08:10AM
05:02AM Loading…
May-16-23 05:02AM
May-15-23 08:22PM
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.